Device Trial Radar · NCT03754296
Treatment of Acute Ischemic Stroke With CATCHVIEW Stent Retriever in Comparison to SOLITAIRE 2/FR
Last checked: Nov 19, 2026Latest source record: Jan 9, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Withdrawn
Enrollment
0
Actual
Start
Dec 2018
Primary completion
Mar 2020
Study completion Mar 2020
Sponsor
- Lead sponsor
- Balt ExtrusionNot on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 27, 2018
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 80 years
Summary
As written by the sponsor on the registry.
The TRUST study is a non-interventional, prospective, multicenter, international, single arm and non-inferiority study. It is designed to evaluate the efficacy and safety of mechanical thrombectomy of the CATCHVIEW device compared to SOLITAIRE 2/FR based on an objective performance criterion (OPC) defined with available and published clinical evidence gathered through the Solitaire clinical trials in the arterial revascularization of patients with acute ischemic stroke.
Conditions
- Acute Ischemic Stroke
Interventions
CATCHVIEWDevice
Revascularization device
Primary outcomes
What the sponsor says the trial is designed to measure.
- modified Rankin Score (mRS)Time frame: 90 days
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.